F
Filterlex Medical
Filterlex created the CAPTIS® intra-aortic EPD to deflect, capture, and remove embolic particles during TAVI. This new EPD offers full-body protection by trapping and eliminating embolic debris
About Filterlex Medical
Developer of an embolic protection device designed to help patients with complications during catheter-based structural heart procedures. The company's device uses next-generation technology to meet the need of current product limitations and weaknesses and is securely positioned in the aorta to provide full-body embolic protection by deflecting, capturing, and removing embolic particles, enabling physicians to reduce the risk of stroke and other complications during catheter-based structural heart procedures.
Source: Dealroom company dataNews
Open roles
Filterlex Medical in the Yokneam Ilit ecosystem
The Filterlex Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Parnasa VC
Alon Medtech Ventures
European Innovation Council
Source: Dealroom Talent Intelligence.
See Filterlex Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

